NEW YORK (GenomeWeb) – Although Drosha is widely known as a key player in microRNA processing, new data out of Mount Sinai Hospital indicating that the RNA nuclease also serves to fight virus infection in mammalian cells, cleaving viral RNA during infection and altering the cellular environment to block replication.

The findings suggest that Drosha may be used by mammalian cells for a task other than that which it evolved to do, and the Mount Sinai team suggests in its study that this repurposing has turned an miRNA-related nuclease into a cellular defender.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In PLOS this week: GWAS links gene to noise-induced hearing loss in mice, population genetics of malaria parasites, and more.

Nautilus' Alexandra Ossola examines how Tay-Sachs disease jump-started the genetic disease testing field.

FASEB says guidelines proposed by the NIH to bolster research reproducibility are premature and don't take the full range of scientific studies into consideration.

Liquid biopsies and DNA tests may be able to tell physicians whether a cancer patient is relapsing, the New York Times reports.